Cutting edge technologies will be used to both discover and characterize human B cell epitopes on bacterial surface antigens known to be involved in immunity to B. Burgdoreri infection.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00069
- Awardee
-
Health Research, Inc. UEI G9H6SUM59YC4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,935,153
Award facts
- Opportunity
-
- Innovations in functional B cell epitope discovery Pre-Solicitation · BAANIAID75N93023R00002 · Posted May 5, 2023
- Contract value 60% obligated
-
- $5,935,153.00 Current, with exercised options
- $9,914,240.00 Potential, with all options
- Completion date 43% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Albany, NY 12204, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $1,903,989 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,571,944 | |
| Other Administrative Action | $650,000 | |
| Original award | $1,809,220 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $9.914 million definitive contract to Health Research, Inc., a tax-exempt nonprofit, on September 16, 2024, to discover and characterize human B cell epitopes on bacterial surface antigens involved in Borrelia burgdorferi immunity using cutting-edge technologies. The contract carries cost-no-fee pricing.
Place of performance is Albany, NY. The ultimate completion date is September 15, 2029. The originating solicitation (posted May 5, 2023) describes applied research to identify and define B cell epitopes on bacterial surface antigens known to confer immunity to B. burgdorferi infection, with delivery expected over approximately five years.
In fiscal year 2025, the contract invoiced $1.2 million against 7,042 contractor hours (3.4 FTEs) at a blended derived government-paid rate of $175.25 per hour. Subcontractors accounted for 86 percent of reported contractor hours in FY2025, with four subcontractors named in SCI reporting. This labor footprint and subcontracting posture reflect the research-intensive nature of epitope discovery and characterization work, with the prime orchestrating specialist scientific delivery across multiple vendors rather than performing research internally.
Quick answers
Who was awarded contract 75N93024C00069?
75N93024C00069 was awarded to Health Research, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2024.
How much is contract 75N93024C00069 worth?
The government has obligated $5,935,153 on 75N93024C00069. Its potential value, with all options, is $9,914,240.
Was contract 75N93024C00069 competed?
The extent of competition for 75N93024C00069 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award